Rddah Mayas, Varalakshmi G, Alkefeiri G, Kaylan M, Pallavarapu S, Milton N, Calleja E
Departments:
Department of urology. Eastbourne District General Hospital
Corresponding Author: Rddah Mayas
Published Date: 11 Nov 2026; Received Date: 09 Oct 2026
Background: Robotic-assisted radical prostatectomy (RARP) is the standard surgical option for localized prostate cancer. Ultra-low intraperitoneal
pressure (ULP, ≤6 mmHg) has become a promising alternative, but there is still limited evidence of its safety, oncological outcomes and feasibility
for use in routine clinical practice.
Aim: To assess the peri-operative, pathological and post-operative results of ULP in RALP at a single centre with a focus on operative efficiency,
oncological safety, complications and feasibility of same day discharge.
Methods: A retrospective observational study from a single tertiary referral centre in the United Kingdom was done from January 2021 to
April 2026 who underwent RARP. Baseline demographic, operative, pathological, and postoperative variables were analysed using descriptive
statistics.
Results: 500 patients had RARP using ULP. The mean console time was 99.67 ± 47.42 minutes, and the mean estimated blood loss was
260.10 ± 131.61mLs. Pelvic lymph node dissection was done in 6.6% of patients and 37.0% were planned as day-case procedures. Bilateral
nerve sparing was performed in 28.8% and unilateral nerve sparing in 50.6% of the cases. Negative surgical margins were obtained in 72.4%
of patients. Post-operative complications were rare, the most common being wound infection (2.2%) and the other complications were seen in
≤1.2% of patients.
Conclusion: ULP in RALP is a feasible, safe, and reproducible technique with good peri- and oncological outcomes. Its low complication rate
and successful implementation of same day discharge make it a good fit for enhanced recovery pathways.
Keywords: Robotic-assisted radical prostatectomy, Ultra-low pneumoperitoneum, Prostate cancer, Same-day discharge, Enhanced recovery
after surgery